Scribd Logo
Upload

Welcome to Scribd!

  • How Did Diiachi Sankyo Acquire Ranbaxy?: Nature of Transaction Acquisition Consideration (In Million Yens)

    Uploaded by

    Prakhar Gupta
    7 views2 pages
    Diiachi Sankyo acquired Ranbaxy through a series of open market share purchases, purchases from the founding family, and new share issuances. The total acquisition consideration paid was 488.354 billion yens, including 169.407 billion for open market shares, 230.970 billion for shares from the founding family, 120.001 billion for new share issuances, and 2.974 billion for direct acquisition expenditures. The acquisition significantly impacted Diiachi Sankyo's balance sheet, with increased losses, cash used for investing activities, short-term bank loans, and borrowings due to the cash-based acquisition of Ranbaxy shares.

    Original Description:

    Valuation

    Original Title

    Ranbaxy Diachy

    Copyright

    © © All Rights Reserved

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Diiachi Sankyo acquired Ranbaxy through a series of open market share purchases, purchases from the founding family, and new share issuances. The total acquisition consideration paid was 488.354 billion yens, including 169.407 billion for open market shares, 230.970 billion for shares from the founding family, 120.001 billion for new share issuances, and 2.974 billion for direct acquisition expenditures. The acquisition significantly impacted Diiachi Sankyo's balance sheet, with increased losses, cash used for investing activities, short-term bank loans, and borrowings due to the cash-based acquisition of Ranbaxy shares.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    7 views2 pages

    How Did Diiachi Sankyo Acquire Ranbaxy?: Nature of Transaction Acquisition Consideration (In Million Yens)

    Uploaded by

    Prakhar Gupta
    Diiachi Sankyo acquired Ranbaxy through a series of open market share purchases, purchases from the founding family, and new share issuances. The total acquisition consideration paid was 488.354 billion yens, including 169.407 billion for open market shares, 230.970 billion for shares from the founding family, 120.001 billion for new share issuances, and 2.974 billion for direct acquisition expenditures. The acquisition significantly impacted Diiachi Sankyo's balance sheet, with increased losses, cash used for investing activities, short-term bank loans, and borrowings due to the cash-based acquisition of Ranbaxy shares.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    HOW DID DIIACHI SANKYO ACQUIRE RANBAXY?

    HOW MUCH DID DIIACHI SANKYO PAID?


    Nature of transaction Open market share purchases Share purchases from founding family Share purchases y issuance of ne! shares $irect ac%uisition related e&penditures Total Acquisition consideration (in million yens) 169,407 230,970 "#,001 2,974 488,354

    IMPACT OF RANBAXY DEAL ON DIIACHI SANKYO BALANCE SHEET


    In Yens billion Net rofit ! (loss) for 97*6 $aiichi'Sankyo in ()200" Net rofit ! (loss) for ("#5$5) $aiichi'Sankyo in ()2009 Net cas% used in in-esting 49*4 acti-ities in ()200" Net cas% used in in-esting 4#3$8 acti-ities in ()2009 &%ort term ban' loans in 0*1 ()200" &%ort term ban' loans in "(4$3 ()2009 Reason +ecording of ,3#1*3 illion in e&traordinary losses due to a one'time !rite'do!n of good!ill pertaining to the in-estment in +an a&y* .t is due to the cash ac%uisitions of shares in /3 0harma and +an a&y, !hich entailed cash outgos*

    1orro!ings for the ac%uisition of +an a&y2s share , 3240*0 illion .ncrease y consolidation of +an a&y

    You might also like